Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of oteseconazole (VT-1161) for acute vulvovaginal candidiasis has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Oteseconazole (VT-1161) (oteseconazole)

Snippet

Sponsor: Viamet | Conditions: Candidiasis, Vulvovaginal | Phase 2 | Status: COMPLETED | Results posted: 2018-07-06